Literature DB >> 29085877

Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats.

Xiaorui Yao1, Fan Xia2, Waijiao Tang3, Chunxin Xiao3, Miaoting Yang3, Benjie Zhou3.   

Abstract

The data presented in this article are related to the research article entitled "Isobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats" (Yao et al., 2017) [1]. This article describes the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats at the level of the proteome (HFD: control, HH: control, HH: HFD, respectively). The field dataset is available to criticize or extended analyzes in public.

Entities:  

Year:  2017        PMID: 29085877      PMCID: PMC5655393          DOI: 10.1016/j.dib.2017.10.027

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data The data make us better known about the pathogenesis of NAFLD and could be used by other researchers for further study. It is an urgent need to further investigate the proteins expression changes which are associated with the treatment of HQT in HFD-induced NAFLD rats. The data provide deeper insight into many cellular pathways and elucidate the underlying mechanism of the effects of HQT in NAFLD treatment.

Data

The original MS/MS file data were performed using the Paragon algorithm [2] as implemented in ProteinPilot Software v4.5. Supplemtary Table 1 lists the data of protein identification and quantification including Uniport Accession, Protein description, Protein unused, Protein mass, Total peptide matches, Sequence Coverages (95%), Unique Peptide Sequence and average fold change of each pair. Supplemtary Table 2 shows the differentially expressed proteins (DEPs) identified by iTRAQ analysis in HFD: control, HH: control, and HH: HFD, respectively. Supplemtary Table 3 lists the pathways, which are annotated in HFD: control, HH: control, and HH: HFD, respectively.

Experimental design, materials and methods

Full methodological details are available in [1]. For data on iTRAQ experiments and subsequent bioinformatics analysis, a flow chart related to the associated research article was shown in Fig. 1.
Fig. 1

Flow chart of data on iTRAQ experiments and subsequent bioinformatics analysis.

Flow chart of data on iTRAQ experiments and subsequent bioinformatics analysis.

Research animals and experimental design

All procedures are described in the associated research article [1].

Protein extraction and digestion and labeling

All procedures are described in the associated research article [1].

Strong cation exchange (SCX) chromatography

All procedures are described in the associated research article [1].

Nano-liquid chromatography and mass spectrometry (MS) analysis and data analysis

All procedures are described in the associated research article [1].
Subject areaPharmacology
More specific subject areaEthnopharmacology
Type of dataTables, Text file
How data was acquirediTRAQ, LC-MS/MS
Data formatGlobally normalized quantitation and analysis
Experimental factorsProtein was extracted from each group (control, HFD and HH) and quantified with iTRAQ
Experimental featuresThe difference of protein expression level among three groups (control, HFD and HH)
Data source locationGuangzhou, China
Data accessibilityThe Data are available with this article
  2 in total

1.  The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra.

Authors:  Ignat V Shilov; Sean L Seymour; Alpesh A Patel; Alex Loboda; Wilfred H Tang; Sean P Keating; Christie L Hunter; Lydia M Nuwaysir; Daniel A Schaeffer
Journal:  Mol Cell Proteomics       Date:  2007-05-27       Impact factor: 5.911

2.  Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.

Authors:  Xiaorui Yao; Fan Xia; Waijiao Tang; Chunxin Xiao; Miaoting Yang; Benjie Zhou
Journal:  J Ethnopharmacol       Date:  2017-10-13       Impact factor: 4.360

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.